Your browser doesn't support javascript.
loading
Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras.
Zhou, Fuling; Krishnamurthy, Janani; Wei, Yongchang; Li, Ming; Hunt, Kelly; Johanning, Gary L; Cooper, Laurence Jn; Wang-Johanning, Feng.
  • Zhou F; Department of Veterinary Sciences; University of Texas MD Anderson Cancer Center ; Houston, TX USA ; Viral Oncology Program; SRI International ; Menlo Park, CA USA ; Department of Clinical Hematology; Second Affiliated Hospital; School of Medicine; Xi'an Jiaotong University ; Xi'an, Shannxi, China.
  • Krishnamurthy J; Division of Pediatrics; University of Texas MD Anderson Cancer Center ; Houston, TX USA ; Graduate School of Biomedical Sciences ; Houston, TX USA.
  • Wei Y; Department of Veterinary Sciences; University of Texas MD Anderson Cancer Center ; Houston, TX USA ; Viral Oncology Program; SRI International ; Menlo Park, CA USA ; Department of Clinical Oncology, First Affiliated Hospital; School of Medicine; Xi'an Jiaotong University , Xi'an, Shannxi, China.
  • Li M; Department of Veterinary Sciences; University of Texas MD Anderson Cancer Center ; Houston, TX USA ; Viral Oncology Program; SRI International ; Menlo Park, CA USA ; Graduate School of Biomedical Sciences ; Houston, TX USA.
  • Hunt K; Department of Surgical Oncology; University of Texas MD Anderson Cancer Center ; Houston, TX USA.
  • Johanning GL; Department of Veterinary Sciences; University of Texas MD Anderson Cancer Center ; Houston, TX USA ; Viral Oncology Program; SRI International ; Menlo Park, CA USA ; Graduate School of Biomedical Sciences ; Houston, TX USA.
  • Cooper LJ; Division of Pediatrics; University of Texas MD Anderson Cancer Center ; Houston, TX USA ; Graduate School of Biomedical Sciences ; Houston, TX USA.
  • Wang-Johanning F; Department of Veterinary Sciences; University of Texas MD Anderson Cancer Center ; Houston, TX USA ; Viral Oncology Program; SRI International ; Menlo Park, CA USA ; Graduate School of Biomedical Sciences ; Houston, TX USA ; Department of Immunology; University of Texas MD Anderson Cancer Center ; H
Oncoimmunology ; 4(11): e1047582, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26451325

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2015 Tipo del documento: Article